View More Recent Stories

Aug 4, 2021 08:00AM F-star Therapeutics Announces Collaboration with MSD to Evaluate FS120 in Combination with KEYTRUDA
Aug 4, 2021 08:00AM F-star Therapeutics Announces Collaboration with MSD to Evaluate FS120 in Combination with KEYTRUDA
Aug 2, 2021 10:10AM F-star Therapeutics to Announce Second Quarter Results and Host Conference Call on August 12, 2021
Aug 2, 2021 10:10AM F-star Therapeutics to Announce Second Quarter Results and Host Conference Call on August 12, 2021
Jul 26, 2021 08:00AM F-star Therapeutics Provides Interim Update on SB 11285 First-In-Human Dose-Escalation Study in Patients with Advanced Solid Tumors
Jul 26, 2021 08:00AM F-star Therapeutics Provides Interim Update on SB 11285 First-In-Human Dose-Escalation Study in Patients with Advanced Solid Tumors
Jul 9, 2021 08:00AM F-star Therapeutics to Present at Upcoming Investor Conferences
Jul 9, 2021 08:00AM F-star Therapeutics to Present at Upcoming Investor Conferences
Jul 8, 2021 08:06AM F-Star Therapeutics (FSTX) Enters into Exclusive Licensing Agreement with AstraZeneca for Novel STING Inhibitors
Jul 8, 2021 08:00AM F-star Therapeutics Enters into Exclusive Licensing Agreement with AstraZeneca for Novel STING Inhibitors
Jul 8, 2021 08:00AM F-star Therapeutics Enters into Exclusive Licensing Agreement with AstraZeneca for Novel STING Inhibitors
May 17, 2021 08:00AM F-star Therapeutics Reports First Quarter 2021 Financial Results and Provides Corporate Update
May 17, 2021 08:00AM F-star Therapeutics Reports First Quarter 2021 Financial Results and Provides Corporate Update
May 10, 2021 08:00AM F-star Therapeutics to Announce First Quarter Results and Corporate Update Call on May 17, 2021
May 10, 2021 08:00AM F-star Therapeutics to Announce First Quarter Results and Corporate Update Call on May 17, 2021
Apr 19, 2021 09:27AM Study Published in Nature Shows F-Star’s STING Agonist SB 11285 Enhances Preclinical Efficacy of Radiation Therapy
Apr 19, 2021 09:27AM Study Published in Nature Shows F-Star’s STING Agonist SB 11285 Enhances Preclinical Efficacy of Radiation Therapy
Apr 10, 2021 09:22AM F-star Therapeutics Shows Differentiation of FS222 in 2021 AACR Poster
Apr 10, 2021 09:22AM F-star Therapeutics Shows Differentiation of FS222 in 2021 AACR Poster
Apr 1, 2021 08:07AM F-Star Therapeutics Inc. (FSTX) Announces Third Option Exercised by Merck KGaA, Darmstadt, Germany in Immuno-Oncology Collaboration
Apr 1, 2021 08:00AM F-star Therapeutics Announces Third Option Exercised by Merck KGaA, Darmstadt, Germany in Immuno-Oncology Collaboration
Apr 1, 2021 08:00AM F-star Therapeutics Announces Third Option Exercised by Merck KGaA, Darmstadt, Germany in Immuno-Oncology Collaboration
Mar 29, 2021 08:00AM F-star Therapeutics Reports Full-Year 2020 Financial Results and Provides Corporate Update
Mar 29, 2021 08:00AM F-star Therapeutics Reports Full-Year 2020 Financial Results and Provides Corporate Update
Mar 16, 2021 08:00AM F-star Therapeutics to Host Full-Year 2020 Investor Call and Provide Corporate Update on March 29, 2021
Mar 16, 2021 08:00AM F-star Therapeutics to Host Full-Year 2020 Investor Call and Provide Corporate Update on March 29, 2021
Mar 4, 2021 08:00AM F-star Therapeutics to Present at Upcoming Investor Conferences
Mar 4, 2021 08:00AM F-star Therapeutics to Present at Upcoming Investor Conferences
View More Recent Stories